Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

PAHC's prospering Vaccine business sparks optimism for future growth. However, headwinds such as unfavorable foreign exchange might hamper the company's operations.

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value ...

Phibro Animal Health PAHC has seen impressive momentum in the past year, with its shares soaring 82.8%. It has significantly outperformed the 9.6% rise of the industry and the S&P 500 Composite ...

Phibro Animal Health Corporation’s PAHC focus on advancing vaccine technologies is poised to drive growth in the upcoming quarters. The company’s global growth prospects look encouraging.

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday morning. Other analysts ...